FDA Moves to Reevaluate Several Peptides American Med Spa Association BPC 157 erectile dysfunction study: what the current evidence actually shows The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA takes first step in possible reversal of ban on some peptides The Washington Post